Medical Oncology

, Volume 28, Supplement 1, pp 333–340 | Cite as

Effect of apoptotic and proliferative indices, P-glycoprotein and survivin expression on prognosis in laryngeal squamous cell carcinoma

Original Paper


This study was to explore the relationship between P-glycoprotein and survivin expression with apoptotic index, proliferative index, clinicopathologic characteristics, and their prognostic value in laryngeal squamous cell carcinoma (LSCC). Samples from 86 patients with LSCC were analyzed for P-glycoprotein, survivin, and Ki-67 expression by immunohistochemistry and apoptotic index by the TUNEL method. The association of P-glycoprotein and survivin expression with clinicopathologic parameters, apoptotic and proliferative activities, and patients’ overall survival was subsequently analyzed. We found that up-regulation of P-glycoprotein expression was associated with decreased apoptosis but not with changes in proliferation, whereas increased survivin expression was correlated with decreased apoptosis and increased proliferation. There was a positive correlation between P-glycoprotein and survivin expression. Expression of these two proteins was significantly related to the clinical stage, histological grade, lymph node metastasis, and overall survival in LSCC. These results reveal that survivin and P-glycoprotein may have an effect on chemotherapy resistance and progression of LSCC through promoting proliferation and/or suppressing apoptosis. Furthermore, our results demonstrate that P-glycoprotein and survivin proteins are both predictive of malignant progression and prognosis of LSCC.


Laryngeal squamous cell carcinoma P-glycoprotein Survivin Apoptosis Cell proliferation Prognosis 



Apoptosis index


Proliferation index




Laryngeal squamous cell carcinoma


  1. 1.
    Chu EA, Kim YJ. Laryngeal cancer: diagnosis and preoperative work-up. Otolaryngol Clin North Am. 2008;41:673–95.PubMedCrossRefGoogle Scholar
  2. 2.
    Hussein MR, Cullen K. Molecular biomarkers in HNSCC: prognostic and therapeutic implications. Expert Rev Anticancer Ther. 2001;1:116–24.PubMedCrossRefGoogle Scholar
  3. 3.
    Pai SI, Westra WH. Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu Rev Pathol. 2009;4:49–70.PubMedCrossRefGoogle Scholar
  4. 4.
    Hipfner DR, Cohen SM. Connecting proliferation and apoptosis in development and disease. Nat Rev Mol Cell Biol. 2004;5:805–15.PubMedCrossRefGoogle Scholar
  5. 5.
    Giménez-Bonafé P, Tortosa A, Pérez-Tomás R. Overcoming drug resistance by enhancing apoptosis of tumor cells. Curr Cancer Drug Targets. 2009;9(3):320–40.PubMedCrossRefGoogle Scholar
  6. 6.
    Gryczyński M, Kobos J, Niewiadomska H, Pietruszewska W. Assessment of cell proliferation antigen Ki-67, protein p53 related to apoptosis and angiogenesis in laryngeal cancer. Otolaryngol Pol. 2000;54(Suppl 31):191–5.PubMedGoogle Scholar
  7. 7.
    Teppo H, Soini Y, Melkko J, Koivunen P, Alho OP. Prognostic factors in laryngeal carcinoma: the role of apoptosis, p53, proliferation (Ki-67) and angiogenesis. APMIS. 2003;111:451–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Itamochi H, et al. Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary. Obstet Gynecol. 2002;100:281–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Licht T, et al. Expression of the proliferation-associated Ki-67 antigen of transferrin receptors and of DNA polymerase alpha in human tumour lines: implications for in vitro chemoresistance. J Cancer Res Clin Oncol. 1992;118(2):116–22.PubMedCrossRefGoogle Scholar
  10. 10.
    Mizutani T, et al. Genuine functions of P-glycoprotein (ABCB1). Curr Drug Metab. 2008;9:167–74.PubMedCrossRefGoogle Scholar
  11. 11.
    Li L, Jiang AC, Dong P, Wan Y, Yu ZW. The characteristics of Hep-2 cell with multiple drug resistance induced by Taxol. Otolaryngol Head Neck Surg. 2007;137:659–64.PubMedCrossRefGoogle Scholar
  12. 12.
    Smyth MJ, Krasovskis E, Sutton VR, Johnstone RW. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis. Proc Natl Acad Sci U S A. 1998;95:7024–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Takanishi K, Miyazaki M, Ohtsuka M, Nakajima N. Inverse relationship between P-glycoprotein expression and its proliferative activity in hepatocellular carcinoma. Oncology. 1997;54:231–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Li L, et al. MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by taxol. Ann Surg Oncol. 2009;16:1421–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Wang B, et al. Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type. Am J Hematol. 2008;83(10):795–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Raspollini MR, Amunni G, Villanucci A, Boddi V, Taddei GL. Increased cyclooxygenase-2 (COX-2) and P-glycoprotein-170 (MDR1) expression is associated with chemotherapy resistance and poor prognosis. Analysis in ovarian carcinoma patients with low and high survival. Int J Gynecol Cancer. 2005;15:255–60.PubMedCrossRefGoogle Scholar
  17. 17.
    Yamamoto H, Ngan CY, Monden M. Cancer cells survive with survivin. Cancer Sci. 2008;99:1709–14.PubMedCrossRefGoogle Scholar
  18. 18.
    Sharma H, Sen S, Lo Muzio L, Mariggiò A, Singh N. Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy. Cancer Biol Ther. 2005;4(7):720–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Mehrotra S, et al. IAP regulation of metastasis. Cancer Cell. 2010;17:53–64.PubMedCrossRefGoogle Scholar
  20. 20.
    Zhao H, et al. Prognostic significance of survivin and CD44v6 in laryngeal cancer surgical margins. J Cancer Res Clin Oncol. 2008;134:1051–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Marioni G, et al. Expression of the apoptosis inhibitor protein survivin in primary laryngeal carcinoma and cervical lymph node metastasis. Anticancer Res. 2006;26:3813–7.PubMedGoogle Scholar
  22. 22.
    Shi Z, et al. Overexpression of survivin and XIAP in MDR cancer cells unrelated to P-glycoprotein. Oncol Rep. 2007;17:969–76.PubMedGoogle Scholar
  23. 23.
    Liu F, et al. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells. Oncol Rep. 2010;23:1469–75.PubMedCrossRefGoogle Scholar
  24. 24.
    Ng IO, Liu CL, Fan ST, Ng M. Expression of P-glycoprotein in hepatocellular carcinoma. A determinant of chemotherapy response. Am J Clin Pathol. 2000;113:355–63.PubMedCrossRefGoogle Scholar
  25. 25.
    Alenzi FQ. Links between apoptosis, proliferation and the cell cycle. Br J Biomed Sci. 2004;61:99–102.PubMedGoogle Scholar
  26. 26.
    Hirvikoski P, et al. Enhanced apoptosis correlates with poor survival in patients with laryngeal cancer but not with cell proliferation, bcl-2 or p53 expression. Eur J Cancer. 1999;35(2):231–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Seymour L, Bezwoda WR, Dansey RD. P-glycoprotein immunostaining correlates with ER and with high Ki67 expression but fails to predict anthracycline resistance in patients with advanced breast cancer. Breast Cancer Res Treat. 1995;36:61–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Sagol O, et al. The effect of apoptotic activity, survivin, Ki-67, and P-glycoprotein expression on prognosis in pancreatic carcinoma. Pancreas. 2005;30(4):343–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Bang CI, Paik SY, Sun DI, Joo YH, Kim MS. Cell growth inhibition and down-regulation of survivin by silibinin in a laryngeal squamous cell carcinoma cell line. Ann Otol Rhinol Laryngol. 2008;117(10):781–5.PubMedGoogle Scholar
  30. 30.
    Chen XM, et al. Suppression of survivin expression by short hairpin RNA induces apoptosis in human laryngeal carcinoma cells. ORL J Otorhinolaryngol Relat Spec. 2008;70(3):168–75.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Otolaryngology-Head & Neck SurgeryShanghai Jiaotong University Affiliated First People’s HospitalShanghaiChina

Personalised recommendations